GlassScriptPhysician profile
Dean Carrington
NPI 1861462491
$1,833.10
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,136 · 2020: $697.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $270.64 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $196.75 | 2019-2020 | |
| Amarin Pharma, INC. | $192.17 | 2019-2020 | |
| Novo Nordisk INC | $171.14 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $105.60 | 2019-2020 | |
| Abbvie INC. | $89.88 | 2019-2020 | |
| Pfizer INC. | $88.64 | 2019 | |
| Astellas Pharma US INC | $77.71 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $77.63 | 2019-2020 | |
| Optinose US, INC. | $63.08 | 2019-2020 | |
| Allergan, INC. | $58.68 | 2020 | |
| Lilly USA, LLC | $52.55 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.73 | 2020 | |
| Silk Road Medical, INC. | $46.39 | 2020 | |
| Eisai INC. | $38.10 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $37.46 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $33.80 | 2019 | |
| Janssen Pharmaceuticals, INC | $32.35 | 2020 | |
| Sanofi Pasteur INC. | $31.30 | 2019 | |
| Avanir Pharmaceuticals, INC. | $28.04 | 2019 | |
| Grifols USA, LLC | $19.79 | 2019 | |
| Ironshore Pharmaceuticals INC. | $17.56 | 2019 | |
| Genentech USA, INC. | $16.81 | 2020 | |
| Mylan Specialty L.P. | $16.51 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.99 | 2019 | |
| Merck Sharp & Dohme LLC | $11.80 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Carrington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.